CIBC World Markets’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
DTC
RI
CIBC World Markets's CYTK Position: Q4 2025 in Review
CIBC World Markets opened a new position in Cytokinetics (CYTK) in Q4 2025: 7,729 shares worth $491K. The stake represents ﹤0.01% of the portfolio and ranks #836 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in CYTK as recently as Q2 2025.
CIBC World Markets first reported a position in CYTK in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.02M in Q1 2025. 431 funds tracked by Wall St. Rank hold CYTK as of Q4 2025.
- CIBC World Markets held 7,729 shares of Cytokinetics worth $491K as of Q4 2025.
- Cytokinetics was a new CIBC World Markets position in Q4 2025.
- Cytokinetics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #836 holding.
- CIBC World Markets first reported a position in Cytokinetics in Q4 2024 and has held it in 4 quarters since.
- CIBC World Markets's Cytokinetics position peaked at $1.02M in Q1 2025.
- 431 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2025.
Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.